Bausch Health Companies Inc. (BHC)
USD 7.34
(-4.43%)
USD 7.34
(-4.43%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 21.93 Billion USD | 7.89% |
| 2022 | 20.33 Billion USD | -10.24% |
| 2021 | 22.65 Billion USD | -5.31% |
| 2020 | 23.92 Billion USD | -2.98% |
| 2019 | 24.66 Billion USD | 0.12% |
| 2018 | 24.63 Billion USD | -2.39% |
| 2017 | 25.23 Billion USD | -15.45% |
| 2016 | 29.84 Billion USD | -1.39% |
| 2015 | 30.26 Billion USD | 98.41% |
| 2014 | 15.25 Billion USD | -11.12% |
| 2013 | 17.16 Billion USD | 62.91% |
| 2012 | 10.53 Billion USD | 61.1% |
| 2011 | 6.53 Billion USD | 82.96% |
| 2010 | 3.57 Billion USD | 840.22% |
| 2009 | 380.17 Million USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 400.62 Million USD | -2.9% |
| 2005 | 412.59 Million USD | -6.69% |
| 2004 | 442.18 Million USD | -42.13% |
| 2003 | 764.11 Million USD | 22.3% |
| 2002 | 624.76 Million USD | 1761.12% |
| 2001 | 33.56 Million USD | -93.96% |
| 2000 | 556.16 Million USD | 343.16% |
| 1999 | 125.5 Million USD | -0.55% |
| 1998 | 126.2 Million USD | 4106.67% |
| 1997 | 3 Million USD | -36.17% |
| 1996 | 4.7 Million USD | -41.25% |
| 1995 | 8 Million USD | -18.37% |
| 1994 | 9.8 Million USD | -54.21% |
| 1993 | 21.4 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 21.05 Billion USD | -0.73% |
| 2024 Q2 | 21.2 Billion USD | -1.42% |
| 2024 Q1 | 21.51 Billion USD | -1.93% |
| 2023 Q3 | 21.89 Billion USD | -17.84% |
| 2023 FY | 21.93 Billion USD | 7.89% |
| 2023 Q4 | 21.93 Billion USD | 0.2% |
| 2023 Q2 | 26.64 Billion USD | 31.87% |
| 2023 Q1 | 20.2 Billion USD | -0.62% |
| 2022 Q4 | 20.33 Billion USD | -2.26% |
| 2022 FY | 20.33 Billion USD | -10.24% |
| 2022 Q1 | 23.16 Billion USD | 2.27% |
| 2022 Q2 | 21.66 Billion USD | -6.49% |
| 2022 Q3 | 20.8 Billion USD | -3.97% |
| 2021 Q3 | 22.35 Billion USD | -4.61% |
| 2021 Q1 | 23.73 Billion USD | -0.78% |
| 2021 Q4 | 22.65 Billion USD | 1.32% |
| 2021 Q2 | 23.43 Billion USD | -1.26% |
| 2021 FY | 22.65 Billion USD | -5.31% |
| 2020 Q4 | 23.92 Billion USD | -1.72% |
| 2020 Q3 | 24.34 Billion USD | -0.06% |
| 2020 FY | 23.92 Billion USD | -2.98% |
| 2020 Q1 | 24.42 Billion USD | -0.96% |
| 2020 Q2 | 24.35 Billion USD | -0.27% |
| 2019 Q1 | 23.92 Billion USD | -2.87% |
| 2019 FY | 24.66 Billion USD | 0.12% |
| 2019 Q4 | 24.66 Billion USD | 5.09% |
| 2019 Q3 | 23.46 Billion USD | -2.32% |
| 2019 Q2 | 24.02 Billion USD | 0.41% |
| 2018 Q4 | 24.63 Billion USD | 0.81% |
| 2018 FY | 24.63 Billion USD | -2.39% |
| 2018 Q3 | 24.43 Billion USD | -1.71% |
| 2018 Q2 | 24.85 Billion USD | -1.61% |
| 2018 Q1 | 25.26 Billion USD | 0.12% |
| 2017 Q4 | 25.23 Billion USD | -3.74% |
| 2017 Q3 | 26.21 Billion USD | -5.18% |
| 2017 Q1 | 28.19 Billion USD | -5.52% |
| 2017 FY | 25.23 Billion USD | -15.45% |
| 2017 Q2 | 27.64 Billion USD | -1.95% |
| 2016 Q2 | 30.77 Billion USD | -1.69% |
| 2016 Q1 | 31.3 Billion USD | 3.43% |
| 2016 FY | 29.84 Billion USD | -1.39% |
| 2016 Q3 | 30.38 Billion USD | -1.26% |
| 2016 Q4 | 29.84 Billion USD | -1.78% |
| 2015 Q4 | 30.26 Billion USD | 0.3% |
| 2015 Q2 | 30.29 Billion USD | 16.96% |
| 2015 FY | 30.26 Billion USD | 98.41% |
| 2015 Q1 | 25.89 Billion USD | 69.78% |
| 2015 Q3 | 30.17 Billion USD | -0.38% |
| 2014 FY | 15.25 Billion USD | -11.12% |
| 2014 Q2 | 17.05 Billion USD | -0.52% |
| 2014 Q3 | 15.58 Billion USD | -8.64% |
| 2014 Q4 | 15.25 Billion USD | -2.12% |
| 2014 Q1 | 17.14 Billion USD | -0.09% |
| 2013 Q3 | 17.04 Billion USD | 63.14% |
| 2013 Q4 | 17.16 Billion USD | 0.7% |
| 2013 Q2 | 10.44 Billion USD | 1.16% |
| 2013 Q1 | 10.32 Billion USD | -1.97% |
| 2013 FY | 17.16 Billion USD | 62.91% |
| 2012 FY | 10.53 Billion USD | 61.1% |
| 2012 Q1 | 6.85 Billion USD | 4.76% |
| 2012 Q2 | 7.35 Billion USD | 7.37% |
| 2012 Q3 | 7.42 Billion USD | 0.9% |
| 2012 Q4 | 10.53 Billion USD | 41.94% |
| 2011 FY | 6.53 Billion USD | 82.96% |
| 2011 Q2 | 4.52 Billion USD | -3.61% |
| 2011 Q3 | 5.18 Billion USD | 14.54% |
| 2011 Q4 | 6.53 Billion USD | 26.06% |
| 2011 Q1 | 4.69 Billion USD | 31.46% |
| 2010 Q1 | 382.77 Million USD | 0.68% |
| 2010 FY | 3.57 Billion USD | 840.22% |
| 2010 Q3 | 3.11 Billion USD | 741.98% |
| 2010 Q4 | 3.57 Billion USD | 14.79% |
| 2010 Q2 | 369.83 Million USD | -3.38% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q4 | 380.17 Million USD | 0.0% |
| 2009 FY | 380.17 Million USD | 0.0% |
| 2009 Q1 | - USD | -100.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | 63.7 Million USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2007 Q2 | - USD | -100.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q1 | 1.33 Million USD | -99.67% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q2 | 400.54 Million USD | -0.23% |
| 2006 FY | 400.62 Million USD | -2.9% |
| 2006 Q1 | 401.46 Million USD | -2.7% |
| 2006 Q3 | 406.32 Million USD | 1.44% |
| 2006 Q4 | 400.62 Million USD | -1.4% |
| 2005 Q3 | 422.64 Million USD | -0.32% |
| 2005 Q1 | 430.72 Million USD | -2.59% |
| 2005 Q2 | 423.99 Million USD | -1.56% |
| 2005 Q4 | 412.59 Million USD | -2.38% |
| 2005 FY | 412.59 Million USD | -6.69% |
| 2004 Q4 | 442.18 Million USD | -12.36% |
| 2004 Q2 | 569.07 Million USD | -15.81% |
| 2004 Q1 | 675.91 Million USD | -11.54% |
| 2004 Q3 | 504.55 Million USD | -11.34% |
| 2004 FY | 442.18 Million USD | -42.13% |
| 2003 Q4 | 764.11 Million USD | 8.91% |
| 2003 Q3 | 701.6 Million USD | -6.37% |
| 2003 Q2 | 749.32 Million USD | 50.98% |
| 2003 Q1 | 496.29 Million USD | -20.56% |
| 2003 FY | 764.11 Million USD | 22.3% |
| 2002 Q4 | 624.76 Million USD | 26.19% |
| 2002 Q1 | 427.74 Million USD | 1174.24% |
| 2002 Q3 | 495.07 Million USD | -2.54% |
| 2002 Q2 | 507.99 Million USD | 18.76% |
| 2002 FY | 624.76 Million USD | 1761.12% |
| 2001 Q4 | 33.56 Million USD | -90.39% |
| 2001 FY | 33.56 Million USD | -93.96% |
| 2001 Q1 | 477 Million USD | -14.23% |
| 2001 Q2 | 474.47 Million USD | -0.53% |
| 2001 Q3 | 349.32 Million USD | -26.38% |
| 2000 Q2 | 300 Million USD | 0.0% |
| 2000 FY | 556.16 Million USD | 343.16% |
| 2000 Q1 | 300 Million USD | 139.04% |
| 2000 Q4 | 556.16 Million USD | 85.39% |
| 2000 Q3 | 300 Million USD | 0.0% |
| 1999 Q2 | 125.9 Million USD | 0.08% |
| 1999 Q3 | 125.5 Million USD | -0.32% |
| 1999 Q4 | 125.5 Million USD | 0.0% |
| 1999 FY | 125.5 Million USD | -0.55% |
| 1999 Q1 | 125.8 Million USD | -0.32% |
| 1998 Q1 | 17.5 Million USD | 483.33% |
| 1998 Q3 | 14.1 Million USD | 42.42% |
| 1998 Q2 | 9.9 Million USD | -43.43% |
| 1998 FY | 126.2 Million USD | 4106.67% |
| 1998 Q4 | 126.2 Million USD | 795.04% |
| 1997 Q1 | 4 Million USD | -14.89% |
| 1997 Q4 | 3 Million USD | -11.76% |
| 1997 Q3 | 3.4 Million USD | -8.11% |
| 1997 Q2 | 3.7 Million USD | -7.5% |
| 1997 FY | 3 Million USD | -36.17% |
| 1996 Q2 | 6.9 Million USD | -5.48% |
| 1996 Q3 | 6.9 Million USD | 0.0% |
| 1996 Q4 | 4.7 Million USD | -31.88% |
| 1996 Q1 | 7.3 Million USD | -8.75% |
| 1996 FY | 4.7 Million USD | -41.25% |
| 1995 Q4 | 8 Million USD | 0.71% |
| 1995 FY | 8 Million USD | -18.37% |
| 1995 Q3 | 7.94 Million USD | 0.13% |
| 1995 Q1 | 4.7 Million USD | -52.04% |
| 1995 Q2 | 7.93 Million USD | 68.8% |
| 1994 Q4 | 9.8 Million USD | 0.0% |
| 1994 FY | 9.8 Million USD | -54.21% |
| 1993 FY | 21.4 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 2.52 Billion USD | -769.555% |
| Catalent, Inc. | 4.54 Billion USD | -382.684% |
| Emergent BioSolutions Inc. | 446.5 Million USD | -4813.326% |
| Elanco Animal Health Incorporated | 5.73 Billion USD | -282.462% |
| Perrigo Company plc | 3.63 Billion USD | -503.887% |
| Teva Pharmaceutical Industries Limited | 18.48 Billion USD | -18.706% |
| Zoetis Inc. | 6.56 Billion USD | -234.217% |